ORKA

Oruka Therapeutics, Inc. - Common Stock (ORKA)

About Oruka Therapeutics, Inc. - Common Stock (ORKA)

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Details

Daily high

$100.73

Daily low

$94.05

Price at open

52 Week High

$115.52

52 Week Low

$25.23

Market cap

6.7B

Dividend yield

Volume

320

Avg. volume

897,301

P/E ratio

-41.18

Oruka Therapeutics, Inc. - Common Stock News